rethinkPeptides Search
Menu
Study breakdown

The Hunger Hormone Ghrelin Drives Stress-Induced Fear Through a New Brain Pathway Linked to PTSD

evidence
The takeaway

Ghrelin, a peptide hormone known for regulating hunger, drives stress-induced enhanced fear learning in the amygdala through a pathway independent of the traditional stress hormone system.

Independent of HPA stress axis

Ghrelin's fear-enhancing effects occurred without changes in corticosterone or CRF, revealing a completely novel branch of the stress response mediated by this peptide hormone.

What the researchers found

The peptide hormone ghrelin drives stress-induced vulnerability to enhanced fear learning through a novel pathway independent of the classical HPA stress axis. Stress-related increases in circulating ghrelin are both necessary and sufficient for exacerbated fear learning, acting through ghrelin receptors in the amygdala. Ghrelin's fear-enhancing effects require growth hormone (GH) in the amygdala — GH was upregulated after chronic stress, its release was enhanced by ghrelin receptor stimulation, and blocking GH receptors prevented ghrelin's fear-enhancing effects. Critically, ghrelin receptor antagonism during stress blocked enhanced fear without affecting corticosterone levels, confirming this is a separate stress response pathway.

Why it matters

PTSD and stress-related disorders have long been linked to the HPA axis (cortisol/corticosterone), but treatments targeting this system have had limited success. This study reveals ghrelin — a peptide better known for regulating hunger — as a mediator of a completely separate stress response branch that directly enhances fear memories in the brain's fear center. This opens new therapeutic targets for PTSD that don't involve the traditional stress hormone pathway.

The numbers in context

Ghrelin receptor agonist enhanced fear memory · ghrelin antagonism blocked stress-enhanced fear · GH upregulated in amygdala after chronic stress · effects independent of CRF and corticosterone

How the study worked

Researchers used a rodent PTSD model where rats repeatedly exposed to stressors develop heightened fear learning via auditory Pavlovian fear conditioning. They used systemic and intraamygdala ghrelin receptor agonist/antagonist administration, virus-mediated overexpression of GH and GH receptor antagonist in the amygdala, and measured circulating ghrelin, corticosterone, CRF, and amygdala GH protein levels.

Who was studied

Male Long-Evans rats in a PTSD model with repeated stress exposure and fear conditioning

What this study cannot tell us

This is a rodent study, and the ghrelin-GH-fear pathway may not translate identically to humans. The PTSD model, while well-established, is a simplified representation of the complex human disorder. The study focused on fear learning rather than other PTSD features like avoidance or hyperarousal. Ghrelin manipulation could affect feeding behavior and metabolism, which may confound behavioral observations.

How to read the evidence

This is a preclinical mechanistic study in rats using multiple complementary approaches (pharmacological, viral overexpression, receptor antagonism) that provide strong convergent evidence for the ghrelin-GH-fear pathway. However, it is an animal study and needs human validation.

When this study was published

Published in 2014, this landmark study identified the ghrelin-GH axis as a novel stress pathway. Subsequent research has explored ghrelin's role in various psychiatric conditions and metabolic-emotional crosstalk.

The bigger picture

This study fundamentally changes our understanding of the hormonal stress response by identifying ghrelin as a mediator of a second, independent stress pathway. It connects the metabolic and emotional stress responses through a peptide previously associated only with appetite. This discovery could explain why PTSD patients often have metabolic disturbances and opens the door to peptide-based therapies targeting the ghrelin-GH axis for stress disorders.

Questions still open

  • Are ghrelin levels elevated in humans with PTSD, and do they correlate with symptom severity?
  • Could ghrelin receptor antagonists serve as a novel treatment for PTSD by preventing fear memory consolidation?
  • Does the ghrelin-GH fear pathway interact with the metabolic effects of chronic stress, such as stress eating and weight gain?

Common questions

How can a hunger hormone affect fear and PTSD?
Ghrelin is best known for making us feel hungry, but it also has receptors in the amygdala — the brain's fear center. This study shows that during chronic stress, elevated ghrelin acts on these receptors to make fear memories stronger. This is separate from the cortisol stress response, meaning the body has a 'second alarm system' for stress that runs through the hunger-regulating peptide system.
Could this lead to new PTSD treatments?
Potentially, yes. The study showed that blocking ghrelin receptors during stress prevented the enhanced fear learning seen in the PTSD model. If this finding translates to humans, drugs that block ghrelin receptors could potentially be given to people after traumatic events to reduce the risk of developing PTSD, or to existing PTSD patients to reduce fear responses.

Read the original research

A ghrelin-growth hormone axis drives stress-induced vulnerability to enhanced fear.

Molecular psychiatry, 19(12), 1284-94

Citation

Meyer, R M; Burgos-Robles, A; Liu, E; Correia, S S; Goosens, K A. (2014). A ghrelin-growth hormone axis drives stress-induced vulnerability to enhanced fear.. Molecular psychiatry, 19(12), 1284-94. https://doi.org/10.1038/mp.2013.135